The distinct expression patterns of our genes of interest and their associations with MCP-1 concentrations in the hippocampus of female TBI donors presenting with dementia allow us to support the previous proposition that MCP-1 may, with future research, serve as a molecular biomarker for TBI and susceptibility to post-injury AD, particularly in females (29). The gene discussed is CCL2; the disease is Alzheimer disease.